• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤促进炎症和抗肿瘤免疫中的黑色素瘤相关成纤维细胞:新机制和潜在的免疫治疗策略。

Melanoma-associated fibroblasts in tumor-promotion flammation and antitumor immunity: novel mechanisms and potential immunotherapeutic strategies.

机构信息

Department of Dermatology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), #54 Youdian Road, Shangcheng District, Hangzhou, Zhejiang 310000, China.

Department of First Clinical Medical College, Zhejiang Chinese Medical University, #548 Binwen Road, Binjiang District, Hangzhou, Zhejiang 310000, China.

出版信息

Hum Mol Genet. 2024 Jun 21;33(13):1186-1193. doi: 10.1093/hmg/ddae056.

DOI:10.1093/hmg/ddae056
PMID:38538564
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11190611/
Abstract

Melanoma, renowned for its aggressive behavior and resistance to conventional treatments, stands as a formidable challenge in the oncology landscape. The dynamic and complex interplay between cancer cells and the tumor microenvironment has gained significant attention, revealing Melanoma-Associated Fibroblasts (MAFs) as central players in disease progression. The heterogeneity of MAFs endows them with a dual role in melanoma. This exhaustive review seeks to not only shed light on the multifaceted roles of MAFs in orchestrating tumor-promoting inflammation but also to explore their involvement in antitumor immunity. By unraveling novel mechanisms underlying MAF functions, this review aims to provide a comprehensive understanding of their impact on melanoma development. Additionally, it delves into the potential of leveraging MAFs for innovative immunotherapeutic strategies, offering new avenues for enhancing treatment outcomes in the challenging realm of melanoma therapeutics.

摘要

黑色素瘤以其侵袭性和对常规治疗的耐药性而闻名,是肿瘤学领域的一个巨大挑战。癌细胞与肿瘤微环境之间的动态和复杂相互作用引起了广泛关注,揭示了黑色素瘤相关成纤维细胞(MAFs)在疾病进展中的核心作用。MAFs 的异质性使它们在黑色素瘤中具有双重作用。这篇全面的综述不仅旨在阐明 MAFs 在调节肿瘤促进炎症中的多方面作用,还探讨了它们在抗肿瘤免疫中的参与。通过揭示 MAF 功能的新机制,本综述旨在全面了解它们对黑色素瘤发展的影响。此外,它还探讨了利用 MAF 进行创新免疫治疗策略的潜力,为黑色素瘤治疗这一极具挑战性的领域提供了提高治疗效果的新途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/216d/11190611/6dbf51a773ce/ddae056f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/216d/11190611/5fe167e8fa0f/ddae056f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/216d/11190611/6dbf51a773ce/ddae056f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/216d/11190611/5fe167e8fa0f/ddae056f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/216d/11190611/6dbf51a773ce/ddae056f2.jpg

相似文献

1
Melanoma-associated fibroblasts in tumor-promotion flammation and antitumor immunity: novel mechanisms and potential immunotherapeutic strategies.肿瘤促进炎症和抗肿瘤免疫中的黑色素瘤相关成纤维细胞:新机制和潜在的免疫治疗策略。
Hum Mol Genet. 2024 Jun 21;33(13):1186-1193. doi: 10.1093/hmg/ddae056.
2
Entering the TiME machine: How age-related changes in the tumor immune microenvironment impact melanoma progression and therapy response.进入 TiME 机器:肿瘤免疫微环境的年龄相关变化如何影响黑色素瘤的进展和治疗反应。
Pharmacol Ther. 2024 Oct;262:108698. doi: 10.1016/j.pharmthera.2024.108698. Epub 2024 Aug 3.
3
Melanoma-associated fibroblasts impair CD8+ T cell function and modify expression of immune checkpoint regulators via increased arginase activity.黑色素瘤相关成纤维细胞通过增加精氨酸酶活性损害 CD8+T 细胞功能,并改变免疫检查点调节剂的表达。
Cell Mol Life Sci. 2021 Jan;78(2):661-673. doi: 10.1007/s00018-020-03517-8. Epub 2020 Apr 23.
4
Influence of Tumor Microenvironment and Fibroblast Population Plasticity on Melanoma Growth, Therapy Resistance and Immunoescape.肿瘤微环境和成纤维细胞群体可塑性对黑色素瘤生长、治疗抗性及免疫逃逸的影响
Int J Mol Sci. 2021 May 17;22(10):5283. doi: 10.3390/ijms22105283.
5
Melanoma-induced immunosuppression and its neutralization.黑色素瘤诱导的免疫抑制及其中和。
Semin Cancer Biol. 2012 Aug;22(4):319-26. doi: 10.1016/j.semcancer.2012.02.003. Epub 2012 Feb 13.
6
Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy?黑色素瘤中的调节性 T 细胞:迈向有效免疫治疗的最后一道难关?
Lancet Oncol. 2012 Jan;13(1):e32-42. doi: 10.1016/S1470-2045(11)70155-3.
7
Microenvironment‑driven resistance to B‑Raf inhibition in a melanoma patient is accompanied by broad changes of gene methylation and expression in distal fibroblasts.微环境驱动的黑色素瘤患者对 B-Raf 抑制的耐药性伴随着远端成纤维细胞中广泛的基因甲基化和表达变化。
Int J Mol Med. 2018 May;41(5):2687-2703. doi: 10.3892/ijmm.2018.3448. Epub 2018 Feb 1.
8
Evolving cancer resistance to anti-PD-1/PD-L1 antibodies in melanoma: Comprehensive insights with future prospects.黑色素瘤中抗 PD-1/PD-L1 抗体的癌症耐药性演变:全面的见解和未来展望。
Crit Rev Oncol Hematol. 2024 Sep;201:104426. doi: 10.1016/j.critrevonc.2024.104426. Epub 2024 Jun 20.
9
Based on scRNA-seq and bulk RNA-seq to establish tumor immune microenvironment-associated signature of skin melanoma and predict immunotherapy response.基于 scRNA-seq 和 bulk RNA-seq 建立皮肤黑色素瘤肿瘤免疫微环境相关特征,并预测免疫治疗反应。
Arch Dermatol Res. 2024 May 25;316(6):262. doi: 10.1007/s00403-024-03080-3.
10
Introduction to the role of the immune system in melanoma.黑色素瘤中免疫系统作用的介绍
Hematol Oncol Clin North Am. 2014 Jun;28(3):537-58. doi: 10.1016/j.hoc.2014.02.005.

引用本文的文献

1
Tumor Microenvironmental Dynamics in Shaping Resistance to Therapeutic Interventions in Melanoma: A Narrative Review.黑色素瘤中肿瘤微环境动力学在塑造对治疗干预的抗性中的作用:一篇综述
Pharmaceuticals (Basel). 2025 Jul 22;18(8):1082. doi: 10.3390/ph18081082.
2
Metabolic Reprogramming in Melanoma: An Epigenetic Point of View.黑色素瘤中的代谢重编程:表观遗传学视角
Pharmaceuticals (Basel). 2025 Jun 6;18(6):853. doi: 10.3390/ph18060853.
3
Double-sided niche regulation in skin stem cell and cancer: mechanisms and clinical applications.

本文引用的文献

1
Single agent vs combination immunotherapy in advanced melanoma: a review of the evidence.单药免疫治疗与联合免疫治疗晚期黑色素瘤:证据回顾。
Curr Opin Oncol. 2024 Mar 1;36(2):69-73. doi: 10.1097/CCO.0000000000001014. Epub 2024 Jan 2.
2
TME-Related Biomimetic Strategies Against Cancer.TME 相关仿生策略防治癌症。
Int J Nanomedicine. 2024 Jan 4;19:109-135. doi: 10.2147/IJN.S441135. eCollection 2024.
3
Expanding CAR-T cell immunotherapy horizons through microfluidics.通过微流控技术拓展 CAR-T 细胞免疫疗法的视野。
皮肤干细胞与癌症中的双侧龛位调控:机制与临床应用
Mol Cancer. 2025 May 21;24(1):147. doi: 10.1186/s12943-025-02289-8.
4
Phase Ib Study of Immunocytokine Simlukafusp Alfa (FAP-IL2v) Combined with Pembrolizumab for Treatment of Advanced and/or Metastatic Melanoma.免疫细胞因子西姆鲁卡福斯 Alfa(FAP-IL2v)联合帕博利珠单抗治疗晚期和/或转移性黑色素瘤的 Ib 期研究。
Cancer Res Commun. 2025 Feb 1;5(2):358-368. doi: 10.1158/2767-9764.CRC-24-0601.
5
The effects of plasma from patients with active thyroid-associated orbitopathy on the survival and inflammation of melanoma-associated fibroblasts.活动性甲状腺相关眼病患者血浆对黑色素瘤相关成纤维细胞存活及炎症的影响
PeerJ. 2024 Nov 27;12:e18612. doi: 10.7717/peerj.18612. eCollection 2024.
Lab Chip. 2024 Feb 27;24(5):1088-1120. doi: 10.1039/d3lc00622k.
4
Single-cell RNA Sequencing Analysis Reveals the Role of Cancerassociated Fibroblasts in Skin Melanoma.单细胞 RNA 测序分析揭示了癌症相关成纤维细胞在皮肤黑色素瘤中的作用。
Curr Med Chem. 2024;31(42):7015-7029. doi: 10.2174/0109298673282799231211113347.
5
IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases.表达 IL-10 的 CAR T 细胞可抵抗功能障碍,介导实体瘤和转移灶的持久清除。
Nat Biotechnol. 2024 Nov;42(11):1693-1704. doi: 10.1038/s41587-023-02060-8. Epub 2024 Jan 2.
6
Engineering Challenges and Opportunities in Autologous Cellular Cancer Immunotherapy.自体细胞癌症免疫疗法的工程挑战与机遇
J Immunol. 2024 Jan 15;212(2):188-198. doi: 10.4049/jimmunol.2300642.
7
The role of immune checkpoints in antitumor response: a potential antitumor immunotherapy.免疫检查点在抗肿瘤反应中的作用:一种潜在的抗肿瘤免疫疗法。
Front Immunol. 2023 Dec 15;14:1298571. doi: 10.3389/fimmu.2023.1298571. eCollection 2023.
8
Combined inflammatory parameters and tertiary lymphoid structure predict prognosis in patients with resectable non-small cell lung cancer treated with neoadjuvant chemoimmunotherapy.联合炎症参数和三级淋巴结构预测新辅助化疗免疫治疗可切除非小细胞肺癌患者的预后。
Front Immunol. 2023 Dec 14;14:1244256. doi: 10.3389/fimmu.2023.1244256. eCollection 2023.
9
The molecular subtypes and clinical prognosis characteristic of tertiary lymphoid structures-related gene of cutaneous melanoma.皮肤黑色素瘤中三级淋巴结构相关基因的分子亚型和临床预后特征。
Sci Rep. 2023 Dec 28;13(1):23097. doi: 10.1038/s41598-023-50327-6.
10
Recent advances and current challenges in CAR-T cell therapy.嵌合抗原受体T细胞(CAR-T)疗法的最新进展与当前挑战
Biotechnol Lett. 2024 Feb;46(1):115-126. doi: 10.1007/s10529-023-03461-0. Epub 2023 Dec 27.